Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Dec;74(11):1693–1698. doi: 10.1038/bjc.1996.616

Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.

D N Aryee 1, I Simonitsch 1, I Mosberger 1, K Kos 1, G Mann 1, E Schlögl 1, U Pötschger 1, H Gadner 1, T Radaszkiewicz 1, H Kovar 1
PMCID: PMC2077220  PMID: 8956779

Abstract

The nm23-H1 gene is a putative metastasis-suppressor gene encoding a 17 kDa protein with nucleoside diphosphate kinase activity. Expression of nm23-H1/NDPK-A correlates inversely with the metastasising potential of some human tumours and experimental animal cells. No nm23 expression studies exist for human malignant lymphomas so far. In this study, we examined nm23-H1 expression by Northern and immunohistochemical analysis in 106 primary lymphoma samples from patients with Hodgkin's disease (HD) (n = 15), high-grade non-Hodgkin's lymphoma (NHL) from different lineages (n = 71) and low-grade NHL (n = 20). Both inter- and intra-subtype variations in nm23-H1/NDPK-A expression levels were demonstrated by all disease subtypes. Besides this heterogeneity, a general trend towards highly malignant samples expressing higher nm23-H1/NDPK-A, levels than the low-grade lymphomas was observed. Both adult and childhood HD and high-grade NHL samples exhibited significantly higher NDPK-A expression than the low-grade NHL found only in adults. High nm23-H1/NDPK-A levels in lymphoma samples did not always reflect proliferative activity of tumour cells as monitored by Ki-67 antigen staining. Fifty samples were further investigated for possible mutations in the nm23-H1 coding sequence by means of reverse transcriptase-polymerase chain reaction (RT-PCR) and single-strand conformation polymorphism (SSCP) analysis. No mutation was found by this screening. Our results suggest a role for nm23-H1 expression in the disease aggressiveness of lymphomas.

Full text

PDF
1698

Images in this article

1695Figure 1
on p.1695
1696Figure 2
on p.1696

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aryee D. N., Ströbel T., Kos K., Salzer-Kuntschik M., Zoubek A., Veron M., Ambros I. M., Traincart F., Gadner H., Kovar H. High nm23-H1/NDPK-A expression in Ewing tumors: paradoxical immunohistochemical reactivity and lack of prognostic significance. Int J Cancer. 1995 Apr 21;64(2):104–111. doi: 10.1002/ijc.2910640206. [DOI] [PubMed] [Google Scholar]
  2. Backer J. M., Mendola C. E., Kovesdi I., Fairhurst J. L., O'Hara B., Eddy R. L., Jr, Shows T. B., Mathew S., Murty V. V., Chaganti R. S. Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene. 1993 Feb;8(2):497–502. [PubMed] [Google Scholar]
  3. Barnes R., Masood S., Barker E., Rosengard A. M., Coggin D. L., Crowell T., King C. R., Porter-Jordan K., Wargotz E. S., Liotta L. A. Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am J Pathol. 1991 Aug;139(2):245–250. [PMC free article] [PubMed] [Google Scholar]
  4. Bevilacqua G., Sobel M. E., Liotta L. A., Steeg P. S. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res. 1989 Sep 15;49(18):5185–5190. [PubMed] [Google Scholar]
  5. Biggs J., Hersperger E., Steeg P. S., Liotta L. A., Shearn A. A Drosophila gene that is homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase. Cell. 1990 Nov 30;63(5):933–940. doi: 10.1016/0092-8674(90)90496-2. [DOI] [PubMed] [Google Scholar]
  6. Chang C. L., Zhu X. X., Thoraval D. H., Ungar D., Rawwas J., Hora N., Strahler J. R., Hanash S. M., Radany E. Nm23-H1 mutation in neuroblastoma. Nature. 1994 Aug 4;370(6488):335–336. doi: 10.1038/370335a0. [DOI] [PubMed] [Google Scholar]
  7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  8. Cohn K. H., Wang F. S., Desoto-LaPaix F., Solomon W. B., Patterson L. G., Arnold M. R., Weimar J., Feldman J. G., Levy A. T., Leone A. Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet. 1991 Sep 21;338(8769):722–724. doi: 10.1016/0140-6736(91)91444-y. [DOI] [PubMed] [Google Scholar]
  9. Engel M., Theisinger B., Seib T., Seitz G., Huwer H., Zang K. D., Welter C., Dooley S. High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages. Int J Cancer. 1993 Sep 30;55(3):375–379. doi: 10.1002/ijc.2910550306. [DOI] [PubMed] [Google Scholar]
  10. Flørenes V. A., Aamdal S., Myklebost O., Maelandsmo G. M., Bruland O. S., Fodstad O. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res. 1992 Nov 1;52(21):6088–6091. [PubMed] [Google Scholar]
  11. Gaynor E. R., Ultmann J. E. Non-Hodgkin's lymphoma: management strategies. N Engl J Med. 1984 Dec 6;311(23):1506–1508. doi: 10.1056/NEJM198412063112309. [DOI] [PubMed] [Google Scholar]
  12. Gilles A. M., Presecan E., Vonica A., Lascu I. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem. 1991 May 15;266(14):8784–8789. [PubMed] [Google Scholar]
  13. Hailat N., Keim D. R., Melhem R. F., Zhu X. X., Eckerskorn C., Brodeur G. M., Reynolds C. P., Seeger R. C., Lottspeich F., Strahler J. R. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest. 1991 Jul;88(1):341–345. doi: 10.1172/JCI115299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hennessy C., Henry J. A., May F. E., Westley B. R., Angus B., Lennard T. W. Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst. 1991 Feb 20;83(4):281–285. doi: 10.1093/jnci/83.4.281. [DOI] [PubMed] [Google Scholar]
  15. Hirayama R., Sawai S., Takagi Y., Mishima Y., Kimura N., Shimada N., Esaki Y., Kurashima C., Utsuyama M., Hirokawa K. Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J Natl Cancer Inst. 1991 Sep 4;83(17):1249–1250. doi: 10.1093/jnci/83.17.1249. [DOI] [PubMed] [Google Scholar]
  16. Horning S. J., Rosenberg S. A. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med. 1984 Dec 6;311(23):1471–1475. doi: 10.1056/NEJM198412063112303. [DOI] [PubMed] [Google Scholar]
  17. Igawa M., Rukstalis D. B., Tanabe T., Chodak G. W. High levels of nm23 expression are related to cell proliferation in human prostate cancer. Cancer Res. 1994 Mar 1;54(5):1313–1318. [PubMed] [Google Scholar]
  18. Kath R., Donhuijsen K., Hayungs J., Albrecht K., Seeber S., Höffken K. Primary gastric non-Hodgkin's lymphoma: a clinicopathological study of 41 patients. J Cancer Res Clin Oncol. 1995;121(1):51–56. doi: 10.1007/BF01202729. [DOI] [PubMed] [Google Scholar]
  19. Keim D., Hailat N., Melhem R., Zhu X. X., Lascu I., Veron M., Strahler J., Hanash S. M. Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase. J Clin Invest. 1992 Mar;89(3):919–924. doi: 10.1172/JCI115672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lacombe M. L., Wallet V., Troll H., Véron M. Functional cloning of a nucleoside diphosphate kinase from Dictyostelium discoideum. J Biol Chem. 1990 Jun 15;265(17):10012–10018. [PubMed] [Google Scholar]
  21. Leone A., Flatow U., King C. R., Sandeen M. A., Margulies I. M., Liotta L. A., Steeg P. S. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell. 1991 Apr 5;65(1):25–35. doi: 10.1016/0092-8674(91)90404-m. [DOI] [PubMed] [Google Scholar]
  22. Leone A., Flatow U., VanHoutte K., Steeg P. S. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene. 1993 Sep;8(9):2325–2333. [PubMed] [Google Scholar]
  23. Leone A., Seeger R. C., Hong C. M., Hu Y. Y., Arboleda M. J., Brodeur G. M., Stram D., Slamon D. J., Steeg P. S. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene. 1993 Apr;8(4):855–865. [PubMed] [Google Scholar]
  24. Nakayama T., Ohtsuru A., Nakao K., Shima M., Nakata K., Watanabe K., Ishii N., Kimura N., Nagataki S. Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst. 1992 Sep 2;84(17):1349–1354. doi: 10.1093/jnci/84.17.1349. [DOI] [PubMed] [Google Scholar]
  25. Postel E. H., Berberich S. J., Flint S. J., Ferrone C. A. Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science. 1993 Jul 23;261(5120):478–480. doi: 10.1126/science.8392752. [DOI] [PubMed] [Google Scholar]
  26. Rosengard A. M., Krutzsch H. C., Shearn A., Biggs J. R., Barker E., Margulies I. M., King C. R., Liotta L. A., Steeg P. S. Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature. 1989 Nov 9;342(6246):177–180. doi: 10.1038/342177a0. [DOI] [PubMed] [Google Scholar]
  27. Sastre-Garau X., Lacombe M. L., Jouve M., Véron M., Magdelénat H. Nucleoside diphosphate kinase/NM23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int J Cancer. 1992 Feb 20;50(4):533–538. doi: 10.1002/ijc.2910500406. [DOI] [PubMed] [Google Scholar]
  28. Stahl J. A., Leone A., Rosengard A. M., Porter L., King C. R., Steeg P. S. Identification of a second human nm23 gene, nm23-H2. Cancer Res. 1991 Jan 1;51(1):445–449. [PubMed] [Google Scholar]
  29. Steeg P. S., Bevilacqua G., Kopper L., Thorgeirsson U. P., Talmadge J. E., Liotta L. A., Sobel M. E. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988 Apr 6;80(3):200–204. doi: 10.1093/jnci/80.3.200. [DOI] [PubMed] [Google Scholar]
  30. Zeng Z. S., Hsu S., Zhang Z. F., Cohen A. M., Enker W. E., Turnbull A. A., Guillem J. G. High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Br J Cancer. 1994 Nov;70(5):1025–1030. doi: 10.1038/bjc.1994.442. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES